KARAKTERISASI MICRORNA TRIPLE HELIX MELALUI METODE HYDROGEL SCAFFOLD SPESIFIK TERHADAP MICRORNA-26A DAN HSA-MICRORNA-15A: MODALITAS KURATIF MUTAKHIR PADA PENYAKIT KATARAK

Nisrina Hanifa Afnan, Endah Sari R.Kumala, Mochammad Afifuddin

Abstract


Cataract is an eye disease that is marked by it decrease in lens transparency. Cataract is a major cause of blindness. Data The World Health Organization (WHO) in 2010 showed that there were 285 million people have visual impairments worldwide, 39 million of them blindness where 33% of them are caused by cataracts. Governance cataracts are currently limited to surgical efforts and administration of eye drops as antioxidant. But both have flaws because of the risk of complications limited ocular and lens penetrating ability. Therefore, the author reviewed the potential for triple helix microRNA characterization through specific Hydrogel Scaffold methods against microRNA-26a and hsa-microRNA-15a as the latest curative modalities on cataract disease. microRNA is a non coding RNA molecule consisting of 22 nucleotide. microRNA is known to have a specific target gene so it will increase the effectiveness of therapy in cataracts. The method used in this writing is a study of literature. The author reviews various sources, the majority come from a global journal. The author enters several keywords such as cataract, microRNA, triplex nanoparticle, and Hydrogel Scaffold. The website is used including nature, sciencedirect, pubmed, and ebsco. After extraction based on the inclusion and exclusion criteria that have been determined, the journal is then analyzed and synthesized whose results are written in this review literature. based on literature obtained, microRNA-26a has decreased expression in cataract cases. So that when microRNA-26a is transfected, there will be an increase in regulation which can increase the positive effect on inhibiting the process of fibrosis on

cataract pathomechanism mediated by Notch / Jagged-1. Meanwhile, microRNA- 15a overexpresses, so that when transfected antagomir microRNA-15a, then this microRNA will decrease and give negative feedback so the expression of bcl-2 and mcl-1 as antiapoptotic and antioxidant proteins will be increased. To increase its stability, both microRNA-26a and antagomir microRNA-15a will be formed into a triple helix RNA structure through addition dendrimer with the Hydogel Scaffold method. This allows the microRNA become more stable in circulation and can be released in specific genes. By therefore, through the triple helix RNA characterization specific to microRNA-15a and microRNA-26a, cataract therapy is expected to be more effective and efficient.

 

Keywords : cataracts, triple helix microRNA, microRNA-15a, microRNA-2


Full Text:

PDF

References


Shiels A, Fielding Hejtmancik J. Molecular genetics of cataract. eLS. 2001 May 30.

Sinha R, Kumar C, Titiyal JS. Etiopathogenesis of cataract: Journal review. Indian journal of ophthalmology. 2009 May;57(3):245.

World Health Organization (2013) ‘Universal eye health: a global action plan 2014-2019.’ ISBN 978 92 4 150656 4

Prokofyeva, E., Wegener, A., & Zrenner, E. (2012). Cataract prevalence and prevention in Europe: a literature review. Acta Ophthalmologica, 91(5), 395–405.doi:10.1111/j.1755-3768.2012.02444.x

Departemen kesehatan Republik Indonesia, 2017. Deteksi Dini ‘Pupil Mata Putih’ Cegah Kebutaan pada Anak, Pusat Penyluhuan Kesehatan, Kesehatan Masyarakat Jakarta : Indonesia

Tabin G, Chen M, Espandar L. Cataract surgery for the developing world. Current opinion in ophthalmology. 2008 Jan 1;19(1):55-9.

Crispim J, Jung LS, Paz L, Allemann N, Schor P. The surgical challenges dense brunescent cataracts present. Expert Review of Ophthalmology. 2015 Jan 2;10(1):13-22.

Dubois VD, Bastawrous A. N‐acetylcarnosine (NAC) drops for age‐related cataract. Cochrane Database of Systematic Reviews. 2017(2).

Hejtmancik JF, Kantorow M. Molecular genetics of age-related cataract. Experimental eye research. 2004 Jul 1;79(1):3-9.

Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO molecular medicine. 2012 Mar 8;4(3):143-59.

Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. cell. 2005 Jan 14;120(1):15-20.

Dunmire JJ, Lagouros E, Bouhenni RA, Jones M, Edward DP. MicroRNA in aqueous humor from patients with cataract. Experimental eye research. 2013 Mar 1;108:68-71.

Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR. MicroRNA expression profiles classify human cancers. nature. 2005 Jun;435(7043):834.

Junn E, Mouradian MM. MicroRNAs in neurodegenerative diseases and their therapeutic potential. Pharmacology & therapeutics. 2012 Feb 1;133(2):142-50.

Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges. Nature reviews Drug discovery. 2014 Aug;13(8):622.

Hejtmancik JF, Kaiser-Kupfer MI, Piatigorsky J. Molecular biology and inherited disorders of the eye lens. In: Scriver CR, Beaudet AL, Valle D, editors. The Metabolic and Molecular Basis of Inherited Disease. 8th ed. New York: McGraw Hill; 2001. pp. 6033–62.

Semina EV, Ferrell RE, Mintz-Hittner HA, Bitoun P, Alward WL, Reiter RS, Funkhauser C, Daack-Hirsch S, Murray JC,Harvey Simon, David Zieve., editors. New York: Time Health Guide; [Last updated and reviewed on 2010 June 23, Last accessed on 16.4.11]

Bigsby RM, Cardenas H, Caperell-Grant A, Grubbs CJ Proc Natl Acad Sci U S A. 1999 Aug 3; 96(16):9328-32.Nat Genet. 1998 Jun; 19(2):167-70.

Yu X, Lyu D, Dong X, He J, Yao K. Hypertension and risk of cataract: a meta-analysis. PloS one. 2014 Dec 4;9(12):e114012.

Mansberger SL, Gordon MO, Jampel H, Bhorade A, Brandt JD, Wilson B, Kass MA, Ocular Hypertension Treatment Study Group. Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study. Ophthalmology. 2012 Sep 1;119(9):1826-31.

Kanthan GL, Wang JJ, Rochtchina E, Mitchell P. Use of antihypertensive medications and topical beta-blockers and the long-term incidence of cataract and cataract surgery. British Journal of Ophthalmology. 2009 Sep 1;93(9):1210-4.

Crasta M, Clode AB, McMullen Jr RJ, Pate DO, Gilger BC. Effect of three treatment protocols on acute ocular hypertension after phacoemulsification and aspiration of cataracts in dogs. Veterinary ophthalmology. 2010 Jan;13(1):14-9.

Sharma KK, Santhoshkumar P. Lens aging: effects of crystallins. Biochimica et Biophysica Acta (BBA)-General Subjects. 2009 Oct 1;1790(10):1095-108.

Truscott, R. J. 2009 Presbyopia. Emerging from a blur towards an understanding of the molecular basis for this most common eye condition. Exp. Eye Res. 88, 241 –247. (doi:10.1016/j.exer.2008.07.003)

Costello, M. J., Johnsen, S., Metlapally, S., Gilliland, K.,

Ramamurthy, B., Krishna, P. & Balasubramanian, D. 2008 Ultrastructural analysis of damage to nuclear fiber cell membranes in advanced age-related cataracts from India. Exp. Eye Res. 87, 147 –158.

Vrensen, G. F. 2009 Early cortical lens opacities: a short overview. Acta Ophthalmol. 87, 602 –610.

Lovicu FJ, Shin EH, McAvoy JW. Fibrosis in the lens. Sprouty regulation of TGFβ-signaling prevents lens EMT leading to cataract. Experimental eye research. 2016 Jan 1;142:92-101.

Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. The Journal of clinical investigation. 2009 Jun 1;119(6):1420-8.

Martinez G, De Iongh RU. The lens epithelium in ocular health and disease. The international journal of biochemistry & cell biology. 2010 Dec 1;42(12):1945-63.

Walker J, Menko AS. Integrins in lens development and disease. Experimental eye research. 2009 Feb 2;88(2):216-25.

Eldred JA, Dawes LJ, Wormstone IM. The lens as a model for fibrotic disease. Philosophical Transactions of the Royal Society B: Biological Sciences. 2011 Apr 27;366(1568):1301-19.

Chen X, Ye S, Xiao W, Wang W, Luo L, Liu Y. ERK1/2 pathway mediates epithelial-mesenchymal transition by cross-interacting with TGFβ/Smad and Jagged/Notch signaling pathways in lens epithelial cells. International journal of molecular medicine. 2014 Jun 1;33(6):1664-70.

Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009 Apr 17;137(2):216-33.

Edeling M, Ragi G, Huang S, Pavenstädt H, Susztak K. Developmental signalling pathways in renal fibrosis: the roles of Notch,Wnt and Hedgehog. Nature Reviews Nephrology. 2016 Jul;12(7):426.

Aoyagi-Ikeda K, Maeno T, Matsui H, Ueno M, Hara K, Aoki Y, Aoki F, Shimizu T, Doi H, Kawai-Kowase K, Iso T. Notch Induces Myofibroblast Differentiation of Alveolar Epithelial Cells via Transforming Growth Factor–β–Smad3 Pathway. American journal of respiratory cell and molecular biology. 2011 Jul;45(1):136-44.

Li L, Xu J, Yang D, Tan X, Wang H. Computational approaches for microRNA studies: a review. Mammalian Genome. 2010 Feb 1;21(1-2):1-2.

Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nature cell biology. 2009 Mar;11(3):228.

Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593–601.

Ru P, Steele R, Newhall P, Phillips NJ, Toth K, Ray RB. miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling. Mol Cancer Ther 2012; 11: 1166–1173.

Siemens H, Jackstadt R, Hunten S, Kaller M, Menssen A, Gotz U et al. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 2011; 10: 4256–4271.

Zhou Q, Fan J, Ding X, Peng W, Yu X, Chen Y et al. TGF-{beta}-induced MiR-491-5p expression promotes Par-3 degradation in rat proximal tubular epithelial cells. J Biol Chem 2010; 285: 40019–40027

Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137: 1005–1017.

Li J, Kong X, Zhang J, Luo Q, Li X, Fang L. MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer. Cancer Cell Int 2013; 13: 7.

Liu XX, Li XJ, Zhang B, Liang YJ, Zhou CX, Cao DX et al. MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Lett 2011; 585: 1363–1367.

Wu N, Zhao X, Liu M, Liu H, Yao W, Zhang Y et al. Role of microRNA-26b in glioma development and its mediated regulation on EphA2. PLoS ONE 2011; 6: e16264.

Wei C, Kim IK, Kumar S, Jayasinghe S, Hong N, Castoldi G et al. NF-kappaB mediated miR-26a regulation in cardiac fibrosis. J Cell Physiol 2013; 228: 1433–1442.

Liang H, Gu Y, Li T, Zhang Y, Huangfu L, Hu M et al. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis. Cell Death Dis 2014; 5: e1238.

Wang Y, Li W, Zang X, Chen N, Liu T, Tsonis PA et al. MicroRNA-204-5p regulates epithelialto-mesenchymal transition during human posterior capsule opacification by targeting SMAD4. Invest Ophthalmol Vis Sci 2013; 54: 323–332.

Dong N, Xu B, Benya SR, Tang X. MiRNA-26b inhibits the proliferation, migration, and epithelial-mesenchymal transition of lens epithelial cells. Mol Cell Biochem 2014; 396: 229–238.

Chen X, Xiao W, Chen W, Liu X, Wu M, Bo Q, Luo Y, Ye S, Cao Y, Liu Y. MicroRNA-26a and-26b inhibit lens fibrosis and cataract by negatively regulating Jagged-1/Notch signaling pathway. Cell death and differentiation. 2017 Aug;24(8):1431.

Saravanamuthu SS, Gao CY, Zelenka PS. Notch signaling is required for lateral induction of Jagged1 during FGF-induced lens fiber differentiation. Developmental biology. 2009 Aug 1;332(1):166-76.

Li Y, Liu S, Zhang F, Jiang P, Wu X, Liang Y. Expression of the microRNAs hsa-miR-15a and hsa-miR-16-1 in lens epithelial cells of patients with age-related cataract. International journal of clinical and experimental medicine. 2015;8(2):2405.

Liu SJ, Wang WT, Zhang FL, Yu YH, Yu HJ, Liang Y, Li N, Li YB. miR-15a-3p affects the proliferation, migration and apoptosis of lens epithelial cells. Molecular medicine reports. 2019 Feb 1;19(2):1110-6.

Mao YW, Xiang H, Wang J, Korsmeyer S, Reddan J, Li DW. Human bcl-2 gene attenuates the ability of rabbit lens epithelial cells against H2O2-induced apoptosis through down-regulation of the αB-crystallin gene. Journal of Biological Chemistry. 2001 Nov 16;276(46):43435-45.

Lee HM, Nguyen DT, Lu LF. Progress and challenge of microRNA research in immunity. Frontiers in genetics. 2014 Jun 12;5:178.

Sethupathy P. The promise and challenge of therapeutic microRNA silencing in diabetes and metabolic diseases. Current diabetes reports. 2016 Jun 1;16(6):52.

Andreasen D, Fog JU, Biggs W, Salomon J, Dahslveen IK, Baker A, Mouritzen P. Improved microRNA quantification in total RNA from clinical samples. Methods. 2010 Apr 1;50(4):S6-9.

Conde J, Oliva N, Atilano M, Song HS, Artzi N. Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment. Nature materials. 2016 Mar;15(3):353.penulisan




DOI: https://doi.org/10.26618/aimj.v3i1.2749

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Nisrina Hanifa Afnan, Endah Sari R.Kumala, Mochammad Afifuddin

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Flag Counter